ARA-290 for Inflammation and Pain Relief
Potential for Neuropathic Pain Studies
$75.00
* This product is strictly for laboratory research use only and must not be used for human consumption, medical treatments, or any other non-research purposes.
What is ARA-290?
ARA-290 is a peptide studied for its role in reducing inflammation and alleviating neuropathic pain by targeting the innate repair receptor (IRR) pathway. It has been explored for chronic inflammatory diseases and pain management.
Mechanism of Action:
ARA-290 interacts with IRR to reduce inflammatory responses and may alleviate nerve pain by modulating immune responses, which has made it valuable for chronic pain research.
Potential Benefits:
Pain Relief: Shows promise in reducing neuropathic pain.
Anti-Inflammatory: Reduces inflammation, particularly in autoimmune conditions.
Enhanced Immune Health: Modulates immune response for chronic inflammation management.
Tissue Repair: Aids in tissue recovery by promoting IRR signaling.
Current Research Areas:
Neuropathy and Pain Management: Its effects on chronic pain, particularly nerve pain.
Autoimmune and Inflammatory Diseases: Explored for reducing inflammation in autoimmune diseases.
Dosage and Administration:
Common Research Dosage: 10-20 mg, administered subcutaneously 2-3 times weekly.
Timing: Taken on non-consecutive days.
Additional Research References:
ScienceDirect: Articles on ARA-290’s pain-relieving properties (ScienceDirect).